Comment · Mon, March 18, 2013
MDMA-Assisted Therapy for Social Anxiety in Autistic Adults: Protocol Submitted to FDA
Original post in this thread
MAPSPsychedelic · 13 points
On February 28, 2013, the protocol ( full protocol ) | synopsis ) for our planned study of MDMA-assisted therapy for social anxiety in autistic adults was submitted to the U.S. Food and Drug Administration for review. This will be a MAPS-sponsored collaborative study between Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the Stanford University School of Medicine. Social anxiety is prevalent in autistic adults, and often compounds the considerable social challenges faced by autistic adults. The main objective of this study is to collect data on the safety of MDMA-assisted therapy in autistic adults, and to use standard clinical measures to estimate the extent to which MDMA-assisted therapy may reduce social anxiety symptoms in this group. Even though we did attempt to obtain external funding from a private foundation, our letter of intent was rejected. Please consider donating to help complete this study.
Alicia Danforth, Ph.D.(c), will present the results of her research on the [MD…
What they were answering
Direct reply to the original post — see the thread post above.
u/MisterYouAreSoDumb
>Previous researchers have also used doses within this range
up to 225mg
Seriously? That's a damn high dose for a therapeutic session. Especially since pharmaceutical grade MDMA is being used. I think your plan on using 125mg as the max dose is a better route. What PTSD studies did you see using 225mg? I've seen most go from 50mg to 150mg. Also, what evidence do you have that autistic subjects will be more sensitive than PTSD subjects?